Regulatory Jury verdict

Abbott Laboratories Ordered to Pay $53M in NEC Lawsuit

Analysis based on 11 articles · First reported Apr 08, 2026 · Last updated Apr 10, 2026

Sentiment

-20

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The verdict against Abbott Laboratories, ordering $53 million in compensatory damages, signals significant financial and reputational risks for the company and potentially for Reckitt Benckiser===Mead Johnson. The ongoing litigation could lead to further substantial payouts and may influence the availability of specialized infant formulas, impacting the broader healthcare and nutrition markets.

Pharmaceuticals Medical devices Food and beverage

Event Summary

A Cook County jury in Chicago ordered Abbott Laboratories to pay $53 million in compensatory damages to four families. The families accused Abbott Laboratories of failing to warn that its cow's milk-based formula for premature infants, Similac Special Care, can cause necrotizing enterocolitis (NEC), a potentially deadly bowel disease. The jury found Abbott Laboratories liable for defective design, failure to adequately warn, and negligence. This verdict is part of over 1,700 lawsuits against Abbott Laboratories and Reckitt Benckiser===Mead Johnson, with previous trials resulting in mixed outcomes, including a $495 million verdict against Abbott Laboratories and a $60 million verdict against Reckitt Benckiser===Mead Johnson. Abbott Laboratories CEO Robert B. Ford has indicated that the company might withdraw its preterm products due to the litigation. The jury will reconvene to determine punitive damages.

Key Actions

100 Abbott Laboratories ordered to pay compensatory damages

90 Abbott Laboratories found liable for defective design, failure to warn, and negligence

70 Robert B. Ford suggested withdrawal of preterm products due to litigation Abbott Laboratories

60 Reckitt Benckiser===Mead Johnson ordered to pay damages in a previous trial

40 American Academy of Pediatrics filed brief supporting Reckitt Benckiser===Mead Johnson's appeal Reckitt Benckiser===Mead Johnson

30 United States===Food and Drug Administration released joint report on NEC risk factors

Entities Involved

stock

Abbott Laboratories

Abbott Laboratories was ordered to pay $53 million in compensatory damages by a Cook County jury for failing to warn that its formula for premature infants can cause necrotizing enterocolitis (NEC). This verdict is part of ongoing litigation, with hundreds of lawsuits filed against the company, and could lead to further financial penalties, including punitive damages. The CEO has suggested the company might pull its preterm products due to litigation.

Importance 100 Sentiment -50

subs

Reckitt Benckiser===Mead Johnson

Reckitt Benckiser===Mead Johnson, a unit of Reckitt, also faces similar lawsuits regarding its Enfamil formula causing NEC. A jury previously ordered Mead Johnson to pay $60 million in a related case, which is currently under appeal. The company's legal challenges are intertwined with those of Abbott Laboratories.

Importance 60 Sentiment -30

per

Robert B. Ford

Robert B. Ford, CEO of Abbott Laboratories, suggested that the company might withdraw its preterm infant formula products from the market due to the ongoing litigation. This statement highlights the significant impact of the lawsuits on Abbott's business strategy and product availability.

Importance 40 Sentiment -20

stock

Reckitt

Reckitt is the parent company of Reckitt Benckiser===Mead Johnson, which is facing lawsuits related to its Enfamil formula. The legal challenges against Mead Johnson could indirectly affect Reckitt's financial performance and reputation.

Importance 30 Sentiment -10

govactor

United States===Food and Drug Administration

The United States===Food and Drug Administration, along with other agencies, released a joint report supporting the hypothesis that the absence of human milk, rather than formula exposure, is associated with an increased risk of NEC. This statement provides a scientific perspective that Abbott Laboratories uses in its defense.

Importance 20 Sentiment 0

govactor

United States===Centers for Disease Control and Prevention

The United States===Centers for Disease Control and Prevention, as part of a joint report, indicated that the absence of human milk, not formula, is linked to an increased risk of NEC. This finding is cited by Abbott Laboratories in its legal defense.

Importance 20 Sentiment 0

govactor

United States===National Institutes of Health

The United States===National Institutes of Health, through a working group report, contributed to a joint statement suggesting that the absence of human milk, rather than formula, is associated with an increased risk of NEC. This scientific backing is used by Abbott Laboratories in its defense.

Importance 20 Sentiment 0

+ 5 more entities View on Dashboard

Relationships

Reckitt Benckiser===Mead Johnson related ↔ Reckitt

Robert B. Ford related ↔ Abbott Laboratories

United States===Food and Drug Administration related ↔ United States===Centers for Disease Control and Prevention

United States===Food and Drug Administration related ↔ United States===National Institutes of Health

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard